InSitu Biologics, Inc — Form D
InSitu Biologics, Inc of Oakdale, MN, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-18. The offering totals $8.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-18
- Form: D
- Accession: 0001723443-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $4.0M
- Remaining: $4.0M
- Investors: 29
- Date of first sale: 2025-11-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-567404
Issuer
- Name: InSitu Biologics, Inc
- CIK: 0001723443
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3510 Hopkins Place N., Oakdale, MN, 55128
- Phone: 651-337-4799
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| Daniel Halpern | Director | Oakdale, MN |
| Ivan Shaw | Director | Oakdale, MN |
| Greg Van Guilder | Director | Golden Valley, MN |
| Robert Wilson | Director | Oakdale, MN |
| Daniel Halpern | Executive Officer | Oakdale, MN |
| Sandi Klemann | Executive Officer | Oakdale, MN |
| Bill Taylor | Executive Officer | Oakdale, MN |
| Kevin Barrett | Executive Officer | San Carlos, CA |
| Buzz Benson | Director | WORCESTER, MA |
| James Knapp | Director | Chicago, IL |
| James Knapp | Executive Officer | Chicago, IL |
| Kevin Bassett | Director | Eden Prairie, MN |
| Kevin Bassett | Executive Officer | Eden Prairie, MN |
| Mark Ereth | Executive Officer | Oakdale, MN |
| Kay Warnott | Executive Officer | Oakdale, MN |
| Andy LaFrence | Director | Oakdale, MN |
| Jim Segermark | Executive Officer | Woodbury, MN |
Other filings by this issuer (5)
More